Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 320.4 Million NZD | -12.41% |
| 2023 | 365.8 Million NZD | 1.92% |
| 2022 | 358.9 Million NZD | 32.63% |
| 2021 | 270.6 Million NZD | 84.71% |
| 2020 | 146.5 Million NZD | 7.64% |
| 2019 | 136.1 Million AUD | 8.53% |
| 2018 | 125.4 Million AUD | -7.1% |
| 2017 | 134.98 Million AUD | 11.6% |
| 2016 | 120.94 Million AUD | 25.8% |
| 2015 | 96.14 Million AUD | 1.77% |
| 2014 | 94.47 Million AUD | 6.02% |
| 2013 | 89.11 Million AUD | 5.54% |
| 2012 | 84.43 Million AUD | 5.4% |
| 2011 | 80.1 Million AUD | 11.62% |
| 2010 | 71.76 Million AUD | 2.6% |
| 2009 | 69.94 Million AUD | 37.77% |
| 2008 | 50.77 Million AUD | 8.72% |
| 2007 | 46.69 Million AUD | 29.03% |
| 2006 | 36.19 Million AUD | 17.1% |
| 2005 | 30.9 Million AUD | 28.37% |
| 2004 | 24.07 Million AUD | 10.18% |
| 2003 | 21.85 Million AUD | 13.72% |
| 2002 | 19.21 Million AUD | 5.18% |
| 2001 | 18.27 Million AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 320.4 Million NZD | -12.41% |
| 2024 Q4 | 320.4 Million NZD | 0.0% |
| 2024 Q2 | 360.1 Million NZD | 8.51% |
| 2024 Q1 | 331.85 Million NZD | -9.28% |
| 2023 Q4 | 365.8 Million NZD | 7.21% |
| 2023 FY | 365.8 Million NZD | 1.92% |
| 2023 Q1 | 360.38 Million NZD | 0.41% |
| 2023 Q2 | 398.4 Million NZD | 10.55% |
| 2023 Q3 | 341.2 Million NZD | -14.36% |
| 2022 Q4 | 358.9 Million NZD | 0.0% |
| 2022 FY | 358.9 Million NZD | 32.63% |
| 2021 Q4 | 270.6 Million NZD | 0.0% |
| 2021 FY | 270.6 Million NZD | 84.71% |
| 2020 Q4 | 146.5 Million NZD | 0.0% |
| 2020 FY | 146.5 Million NZD | 7.64% |
| 2019 Q4 | 136.1 Million AUD | 0.0% |
| 2019 FY | 136.1 Million AUD | 8.53% |
| 2018 FY | 125.4 Million AUD | -7.1% |
| 2018 Q4 | 125.4 Million AUD | 0.0% |
| 2017 Q4 | 134.98 Million AUD | 0.0% |
| 2017 FY | 134.98 Million AUD | 11.6% |
| 2016 FY | 120.94 Million AUD | 25.8% |
| 2016 Q4 | 120.94 Million AUD | 0.0% |
| 2015 FY | 96.14 Million AUD | 1.77% |
| 2015 Q4 | 96.14 Million AUD | 0.0% |
| 2014 Q4 | 94.47 Million AUD | 0.0% |
| 2014 FY | 94.47 Million AUD | 6.02% |
| 2013 FY | 89.11 Million AUD | 5.54% |
| 2013 Q4 | 89.11 Million AUD | 0.0% |
| 2012 Q4 | 84.43 Million AUD | 0.0% |
| 2012 FY | 84.43 Million AUD | 5.4% |
| 2011 Q4 | 80.1 Million AUD | 0.0% |
| 2011 FY | 80.1 Million AUD | 11.62% |
| 2010 Q4 | 71.76 Million AUD | 0.0% |
| 2010 FY | 71.76 Million AUD | 2.6% |
| 2009 FY | 69.94 Million AUD | 37.77% |
| 2009 Q4 | 69.94 Million AUD | 0.0% |
| 2008 FY | 50.77 Million AUD | 8.72% |
| 2008 Q4 | 50.77 Million AUD | 0.0% |
| 2007 Q4 | 46.69 Million AUD | 0.0% |
| 2007 FY | 46.69 Million AUD | 29.03% |
| 2006 FY | 36.19 Million AUD | 17.1% |
| 2006 Q4 | 36.19 Million AUD | 0.0% |
| 2005 FY | 30.9 Million AUD | 28.37% |
| 2005 Q4 | 30.9 Million AUD | 0.0% |
| 2004 Q4 | 24.07 Million AUD | 0.0% |
| 2004 FY | 24.07 Million AUD | 10.18% |
| 2003 Q4 | 21.85 Million AUD | 0.0% |
| 2003 FY | 21.85 Million AUD | 13.72% |
| 2002 FY | 19.21 Million AUD | 5.18% |
| 2001 FY | 18.27 Million AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -239309.993% |
| Ansell Limited | 457.04 Million USD | 29.897% |
| Ansell Limited | 457.9 Million USD | 30.028% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -639.345% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -1148698.853% |
| Psykey, Inc. | 49.94 Thousand USD | -641469.884% |
| ConvaTec Group Plc | 395.54 Million USD | 18.997% |
| ConvaTec Group Plc | 396.1 Million USD | 19.111% |
| Encision Inc. | 1.4 Million USD | -22747.559% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 3447485.41% |
| LifePoint, Inc. | 2.3 Million USD | -13774.076% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -13233.333% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -72553.061% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -348608.126% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -32853.03% |
| SmileDirectClub, Inc. | 49.87 Million USD | -542.419% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 8.912% |
| SheerVision, Inc. | 339.66 Thousand USD | -94228.791% |
| United Health Products, Inc. | 33.59 Thousand USD | -953528.192% |
| Vasamed, Inc. | 449.02 Thousand USD | -71254.125% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -3745078.258% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -99349.675% |